Emergence of Morganellaceae Harboring blaIMP-27 Metalloenzyme in Canada
Related Experiment Video
Updated: Jun 26, 2026

Multiplex Detection of Bacteria in Complex Clinical and Environmental Samples using Oligonucleotide-coupled Fluorescent Microspheres
Published on: October 23, 2011
David A Boyd1, Laura F Mataseje2, Tanis Dingle3
1Antimicrobial Resistance & Nosocomial Infections, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada david.boyd@canada.ca.
Abstract:
In 2018 to 2019, PCR for carbapenemases in routine Gram-negative isolates submitted to the National Microbiology Laboratory revealed an increase in IMP-type metalloenzyme-positive isolates, mostly among Morganellaceae Whole-genome sequencing revealed that 23 Morganellaceae harbored blaIMP-27 within a chromosomal Tn7 element. Phylogenomics indicated diversity of isolates but also the presence of a few clonal isolates dispersed geographically. These isolates may be difficult to detect due to carbapenem susceptibility and false-negative results in phenotypic testing.IMPORTANCE Over the last decade or so, the frequency of isolation of clinical carbapenemase-producing organisms (CPOs) has increased among health care-associated infections. This may seriously compromise antimicrobial therapy, as carbapenems are considered the last line of defense against these organisms. The ability of carbapenemases to hydrolyze most β-lactams in addition to the co-occurrence of mechanisms of resistance to other classes of antimicrobials in CPOs can leave few options for treating infections. The class B metalloenzymes are globally distributed carbapenemases, and the most commonly found include the NDM, VIM, and IMP types. Our study describes a sudden emergence of IMP-27-harboring Morganellaceae during 2018 to 2019 in Canada. There is a paucity of literature on IMP-27 isolates, and our data bolster the information on the genetic context, antimicrobial profiles, and phylogenomics of this group of CPOs.
Insights
Carbapenemase-producing organisms (CPOs) are a growing threat. A study found a sudden increase in IMP-27 carbapenemase-producing Morganellaceae in Canada, posing diagnostic challenges.
Area of Science:
- Clinical microbiology
- Genomics
- Antimicrobial resistance
Background:
- Carbapenemase-producing organisms (CPOs) are a significant threat to healthcare, compromising last-line antibiotic therapies.
- Class B metalloenzymes, including IMP types, are globally distributed resistance mechanisms.
- The emergence of novel carbapenemase variants like IMP-27 requires ongoing surveillance.
Purpose of the Study:
- To report the emergence of IMP-27-harboring Morganellaceae in Canada.
- To characterize the genetic context and phylogenetic diversity of these isolates.
- To highlight potential challenges in detecting these carbapenem-susceptible CPOs.
Main Methods:
- Polymerase chain reaction (PCR) for carbapenemase detection.
- Whole-genome sequencing (WGS) for genetic analysis.
- Phylogenomic analysis to assess isolate relationships.
Main Results:
- An increase in IMP-type metalloenzyme-positive isolates, primarily among Morganellaceae, was detected in 2018-2019.
- Whole-genome sequencing identified the bla_IMP-27 gene within a Tn7 element in 23 Morganellaceae isolates.
- Phylogenomics revealed isolate diversity and geographical dispersion, with some clonal spread.
Conclusions:
- The study documents the emergence of IMP-27-producing Morganellaceae in Canada.
- These isolates may evade detection due to carbapenem susceptibility and false-negative phenotypic tests.
- Further research on IMP-27's genetic and clinical impact is warranted.
Related Concept Videos
Other Unique Bacteria
Green Algae
Microbes and Other Elemental Cycles
Deep Sea Microbial Ecology
Rapid Identification of Pathogens

